Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study

Abstract Background Mesentericoportal vein (MPV) resection in pancreatic ductal adenocarcinoma (PDAC) surgery has become a common procedure. A few studies had described the use of falciform ligament (FL) for MPV reconstruction and received encouraging preliminary effects. Aims This study was designe...

Full description

Bibliographic Details
Main Authors: Yi Shao, Jiaojiao Feng, Yuancong Jiang, Zhenhua Hu, Jian Wu, Min Zhang, Yan Shen, Shusen Zheng
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Surgery
Subjects:
Online Access:https://doi.org/10.1186/s12893-020-01019-9
id doaj-4bda5857023c4de9a29c42d3c60673ab
record_format Article
spelling doaj-4bda5857023c4de9a29c42d3c60673ab2021-01-10T12:33:30ZengBMCBMC Surgery1471-24822021-01-012111810.1186/s12893-020-01019-9Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort studyYi Shao0Jiaojiao Feng1Yuancong Jiang2Zhenhua Hu3Jian Wu4Min Zhang5Yan Shen6Shusen Zheng7Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDepartment of Gynecologic Oncology, Women’s Hospital, School of Medicine, Zhejiang UniversityDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityDepartment of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang UniversityAbstract Background Mesentericoportal vein (MPV) resection in pancreatic ductal adenocarcinoma (PDAC) surgery has become a common procedure. A few studies had described the use of falciform ligament (FL) for MPV reconstruction and received encouraging preliminary effects. Aims This study was designed to explore the feasibility and efficacy of this technique compared with others. Methods Patients who underwent pancreaticoduodenectomy (PD) with MPV resection for PDAC from 2009 to 2018 were enrolled. Medical records were retrospectively reviewed, MPV reconstructions using FL were distinguished and compared with other techniques. Results 146 patients underwent MPV reconstruction, and 13 received FL venoplasty. Other reconstruction techniques included primary end-to-end anastomosis (primary, n = 30), lateral venorrhaphy (LV, n = 19), polytetrafluoroethylene conduit interposition (PTFE, n = 24), iliac artery (IA) allografts interposition (n = 47), and portal vein (PV) allografts interposition (n = 13). FL group holds the advantages of shortest operation time (p = 0.023), lowest blood loss (p = 0.109), and shortest postoperative hospital stay (p = 0.125). The grouped patency rates of FL, primary, LV, PTFE, IA, and PV were 100%, 90%, 68%, 54%, 68%, and 85% respectively. Comparison displayed that FL had the highest patency rate (p = 0.008) and lowest antiplatelet/anticoagulation proportion (p = 0.000). Complications and long-term survival were similar among different techniques. The median survival time of patent group (24.0 months, 95% CI: 22.0–26.0) was much longer than that of the thrombosed (17.0 months, 95% CI: 13.7–20.3), though without significant difference (P = 0.148). Conclusions PD with MPV resection and reconstruction by FL is safe, feasible, and efficacious, it might provide a potential benefit for patients.https://doi.org/10.1186/s12893-020-01019-9Pancreatic cancerVenous reconstruction techniqueFalciform ligamentPatencySurvival
collection DOAJ
language English
format Article
sources DOAJ
author Yi Shao
Jiaojiao Feng
Yuancong Jiang
Zhenhua Hu
Jian Wu
Min Zhang
Yan Shen
Shusen Zheng
spellingShingle Yi Shao
Jiaojiao Feng
Yuancong Jiang
Zhenhua Hu
Jian Wu
Min Zhang
Yan Shen
Shusen Zheng
Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study
BMC Surgery
Pancreatic cancer
Venous reconstruction technique
Falciform ligament
Patency
Survival
author_facet Yi Shao
Jiaojiao Feng
Yuancong Jiang
Zhenhua Hu
Jian Wu
Min Zhang
Yan Shen
Shusen Zheng
author_sort Yi Shao
title Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study
title_short Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study
title_full Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study
title_fullStr Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study
title_full_unstemmed Feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study
title_sort feasibility of mesentericoportal vein reconstruction by autologous falciform ligament during pancreaticoduodenectomy—cohort study
publisher BMC
series BMC Surgery
issn 1471-2482
publishDate 2021-01-01
description Abstract Background Mesentericoportal vein (MPV) resection in pancreatic ductal adenocarcinoma (PDAC) surgery has become a common procedure. A few studies had described the use of falciform ligament (FL) for MPV reconstruction and received encouraging preliminary effects. Aims This study was designed to explore the feasibility and efficacy of this technique compared with others. Methods Patients who underwent pancreaticoduodenectomy (PD) with MPV resection for PDAC from 2009 to 2018 were enrolled. Medical records were retrospectively reviewed, MPV reconstructions using FL were distinguished and compared with other techniques. Results 146 patients underwent MPV reconstruction, and 13 received FL venoplasty. Other reconstruction techniques included primary end-to-end anastomosis (primary, n = 30), lateral venorrhaphy (LV, n = 19), polytetrafluoroethylene conduit interposition (PTFE, n = 24), iliac artery (IA) allografts interposition (n = 47), and portal vein (PV) allografts interposition (n = 13). FL group holds the advantages of shortest operation time (p = 0.023), lowest blood loss (p = 0.109), and shortest postoperative hospital stay (p = 0.125). The grouped patency rates of FL, primary, LV, PTFE, IA, and PV were 100%, 90%, 68%, 54%, 68%, and 85% respectively. Comparison displayed that FL had the highest patency rate (p = 0.008) and lowest antiplatelet/anticoagulation proportion (p = 0.000). Complications and long-term survival were similar among different techniques. The median survival time of patent group (24.0 months, 95% CI: 22.0–26.0) was much longer than that of the thrombosed (17.0 months, 95% CI: 13.7–20.3), though without significant difference (P = 0.148). Conclusions PD with MPV resection and reconstruction by FL is safe, feasible, and efficacious, it might provide a potential benefit for patients.
topic Pancreatic cancer
Venous reconstruction technique
Falciform ligament
Patency
Survival
url https://doi.org/10.1186/s12893-020-01019-9
work_keys_str_mv AT yishao feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy
AT jiaojiaofeng feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy
AT yuancongjiang feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy
AT zhenhuahu feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy
AT jianwu feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy
AT minzhang feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy
AT yanshen feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy
AT shusenzheng feasibilityofmesentericoportalveinreconstructionbyautologousfalciformligamentduringpancreaticoduodenectomycohortstudy
_version_ 1724342646704439296